Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study

NCT01306981 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Retinopathy
Retinal Neovascularisation

Interventions

DRUG: Ranibizumab
DRUG: Saline

Sponsor

Moorfields Eye Hospital NHS Foundation Trust

Collaborators

[object Object]